108 related articles for article (PubMed ID: 10871755)
21. [Quality control of clinical-grade recombinant adenovirus used in gene therapy].
Zhang XZ; Lin H; Yang XY; Wang CH; Zhang MM; Chen PL; Peng ZH
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):849-52. PubMed ID: 15200892
[TBL] [Abstract][Full Text] [Related]
22. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
Burova E; Ioffe E
Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
[TBL] [Abstract][Full Text] [Related]
23. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
24. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.
Qu G; Bahr-Davidson J; Prado J; Tai A; Cataniag F; McDonnell J; Zhou J; Hauck B; Luna J; Sommer JM; Smith P; Zhou S; Colosi P; High KA; Pierce GF; Wright JF
J Virol Methods; 2007 Mar; 140(1-2):183-92. PubMed ID: 17196264
[TBL] [Abstract][Full Text] [Related]
25. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration.
Ugai H; Yamasaki T; Hirose M; Inabe K; Kujime Y; Terashima M; Liu B; Tang H; Zhao M; Murata T; Kimura M; Pan J; Obata Y; Hamada H; Yokoyama KK
Biochem Biophys Res Commun; 2005 Jun; 331(4):1053-60. PubMed ID: 15882984
[TBL] [Abstract][Full Text] [Related]
26. Serotype specificity of adenovirus purification using anion-exchange chromatography.
Konz JO; Livingood RC; Bett AJ; Goerke AR; Laska ME; Sagar SL
Hum Gene Ther; 2005 Nov; 16(11):1346-53. PubMed ID: 16259569
[TBL] [Abstract][Full Text] [Related]
27. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
[TBL] [Abstract][Full Text] [Related]
28. Improved high-performance liquid chromatographic method in the analysis of adenovirus particles.
Klyushnichenko V; Bernier A; Kamen A; Harmsen E
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):27-36. PubMed ID: 11393714
[TBL] [Abstract][Full Text] [Related]
29. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.
Konz JO; Lee AL; Lewis JA; Sagar SL
Biotechnol Prog; 2005; 21(2):466-72. PubMed ID: 15801787
[TBL] [Abstract][Full Text] [Related]
30. Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3.
Chahal PS; Transfiguracion J; Bernier A; Voyer R; Coffey M; Kamen A
J Pharm Biomed Anal; 2007 Nov; 45(3):417-21. PubMed ID: 17692493
[TBL] [Abstract][Full Text] [Related]
31. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.
Wang F; Puddy AC; Mathis BC; Montalvo AG; Louis AA; McMackin JL; Xu J; Zhang Y; Tan CY; Schofield TL; Wolf JJ; Lewis JA
Vaccine; 2005 Aug; 23(36):4500-8. PubMed ID: 16002190
[TBL] [Abstract][Full Text] [Related]
32. Manipulating adenoviral vector ion-exchange chromatography: Hexon versus fiber.
Ruščić J; Ambriović-Ristov A; Majhen D; Kolundžija S; Barut M; Benihoud K; Krajačić M
J Sep Sci; 2016 Nov; 39(22):4299-4304. PubMed ID: 27662513
[TBL] [Abstract][Full Text] [Related]
33. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
[TBL] [Abstract][Full Text] [Related]
34. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
35. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
[TBL] [Abstract][Full Text] [Related]
36. A simple method for the simultaneous detection of E1A and E1B in adenovirus stocks.
Suzuki E; Murata T; Watanabe S; Kujime Y; Hirose M; Pan J; Yamazaki T; Ugai H; Yokoyama KK
Oncol Rep; 2004 Jan; 11(1):173-8. PubMed ID: 14654922
[TBL] [Abstract][Full Text] [Related]
37. Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process.
Thorne BA; Quigley P; Nichols G; Moore C; Pastor E; Price D; Ament JW; Takeya RK; Peluso RW
Biologicals; 2008 Jan; 36(1):7-18. PubMed ID: 17644406
[TBL] [Abstract][Full Text] [Related]
38. Quantifying the titer and quality of adenovirus stocks.
Wang F; Mathis BC; Montalvo A; Wolf JJ; Lewis JA
Methods Mol Biol; 2008; 434():25-36. PubMed ID: 18470637
[TBL] [Abstract][Full Text] [Related]
39. Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation.
Kroes AC; de Klerk EP; Lankester AC; Malipaard C; de Brouwer CS; Claas EC; Jol-van der Zijde EC; van Tol MJ
J Clin Virol; 2007 Apr; 38(4):341-7. PubMed ID: 17317293
[TBL] [Abstract][Full Text] [Related]
40. Towards purification of adenoviral vectors based on membrane technology.
Peixoto C; Ferreira TB; Sousa MF; Carrondo MJ; Alves PM
Biotechnol Prog; 2008; 24(6):1290-6. PubMed ID: 19194943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
